MetLife Investment Management, LLC - BIOSCRIP INC ownership

BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 108 filers reported holding BIOSCRIP INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of BIOSCRIP INC
ValueSharesWeighting
Q2 2019$162,297
+30.0%
62,4220.0%0.00%
+100.0%
Q1 2019$124,844
-44.0%
62,4220.0%0.00%
-66.7%
Q4 2018$222,847
+15.2%
62,4220.0%0.00%
+50.0%
Q3 2018$193,508
+1.8%
62,422
-3.6%
0.00%0.0%
Q2 2018$190,000
+280.0%
64,727
+220.8%
0.00%
+100.0%
Q1 2018$50,000
-71.3%
20,179
-66.3%
0.00%
-50.0%
Q4 2017$174,00059,8030.00%
Other shareholders
BIOSCRIP INC shareholders Q2 2018
NameSharesValueWeighting ↓
KEANE CAPITAL MANAGEMENT INC 894,943$3,965,0003.86%
DSC Advisors, L.P. 1,200,000$5,316,0002.82%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 2,208,710$9,785,0001.96%
ARDSLEY ADVISORY PARTNERS LP 3,010,000$13,335,0001.85%
First Washington CORP 709,600$3,144,0001.82%
WYNNEFIELD CAPITAL INC 505,500$2,239,0000.99%
Camber Capital Management LP 3,000,000$13,290,0000.95%
MARATHON CAPITAL MANAGEMENT 478,800$2,121,0000.94%
KING INVESTMENT ADVISORS INC/TX 315,040$1,402,0000.67%
THB ASSET MANAGEMENT 2,082,955$9,227,0000.64%
View complete list of BIOSCRIP INC shareholders